Literature DB >> 25370482

Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.

Jie Zhang1, Tianyou Ling2, Hanjiang Wu2, Kai Wang2.   

Abstract

BACKGROUND: Lactotransferrin (LTF) has been confirmed to act as a tumor suppressor in multiple cancers; however, its roles in oral squamous cell carcinoma (OSCC), one of malignant head and neck carcinomas, has not been explored.
METHODS: Here, the expression of LTF in OSCC tissues and TCA8113 cells was detected with RT-PCR, qPCR, and IHC. And the correlation between LTF expression and OSCC metastasis was assessed. MS-PCR was performed to reveal the methylation status in promoter regions of LTF both in OSCC tissue samples and cells. The influences of 5-Aza-Cdc treatment to the methylation status and expression levels of LTF were also analyzed. At last, the functions of LTF in OSCC progression were demonstrated by MTT analysis, clone formation assay, and cell cycle analysis in TCA8113 cells with forced ectopic expression of LTF.
RESULTS: LTF showed a low or null expression pattern in OSCC tissues and cells, at least partially, due to the hypermethylated status in promoter regions for 5-Aza-Cdc, a methyltransferase inhibitor, could restore the expression of LTF in TCA8113 cells. And the expression level of LTF exhibited a negative correlation with OSCC metastasis.
CONCLUSIONS: Re-expression of LTF inhibited the growth, proliferation, as well as cell cycle progression of TCA8113 cells. In conclusion, hypermethylation contributes much to LTF inactivation in OSCC. And LTF can partially reverse the malignant phenotypes of OSCC cells and may be served as a potential target for diagnosis and therapy of OSCC in future.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MS-PCR; hypermethylation; lactotransferrin; metastasis; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2014        PMID: 25370482     DOI: 10.1111/jop.12279

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  5 in total

1.  Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  Lihua Ni; Cheng Yuan; Changjiang Zhang; Yuandi Xiang; Juan Wu; Xiaolong Wang; Xiaoyan Wu
Journal:  Onco Targets Ther       Date:  2020-07-17       Impact factor: 4.147

2.  Identification of LTF as a Prognostic Biomarker for Osteosarcoma.

Authors:  Xiaoqi Liu; Zengqiang Wang; Meijiao Liu; Fengnan Zhi; Pengpeng Wang; Xingyu Liu; Shanxiao Yu; Bing Liu; Yanan Jiang
Journal:  J Oncol       Date:  2022-01-21       Impact factor: 4.375

3.  Identification of potential gene signatures associated with osteosarcoma by integrated bioinformatics analysis.

Authors:  Yutao Jia; Yang Liu; Zhihua Han; Rong Tian
Journal:  PeerJ       Date:  2021-05-27       Impact factor: 2.984

4.  Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.

Authors:  Rujia Qin; Chunyan Li; Xuemin Wang; Zhaoming Zhong; Chuanzheng Sun
Journal:  Cancer Cell Int       Date:  2021-07-15       Impact factor: 5.722

Review 5.  Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.

Authors:  Antimo Cutone; Luigi Rosa; Giusi Ianiro; Maria Stefania Lepanto; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci
Journal:  Biomolecules       Date:  2020-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.